Okyo Pharma Ltd Stock Probability of Future Stock Price Finishing Over 1.41
| OKYO Stock | USD 1.07 0.03 2.88% |
OKYO |
OKYO Pharma Target Price Odds to finish over 1.41
The tendency of OKYO Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 1.41 or more in 90 days |
| 1.07 | 90 days | 1.41 | near 1 |
Based on a normal probability distribution, the odds of OKYO Pharma to move over $ 1.41 or more in 90 days from now is near 1 (This OKYO Pharma Ltd probability density function shows the probability of OKYO Stock to fall within a particular range of prices over 90 days) . Probability of OKYO Pharma price to stay between its current price of $ 1.07 and $ 1.41 at the end of the 90-day period is about 43.29 .
Given the investment horizon of 90 days OKYO Pharma Ltd has a beta of -0.42. This indicates as returns on the benchmark increase, returns on holding OKYO Pharma are expected to decrease at a much lower rate. During a bear market, however, OKYO Pharma Ltd is likely to outperform the market. Additionally OKYO Pharma Ltd has an alpha of 0.1979, implying that it can generate a 0.2 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). OKYO Pharma Price Density |
| Price |
Predictive Modules for OKYO Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as OKYO Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of OKYO Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
OKYO Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. OKYO Pharma is not an exception. The market had few large corrections towards the OKYO Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold OKYO Pharma Ltd, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of OKYO Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.20 | |
β | Beta against Dow Jones | -0.42 | |
σ | Overall volatility | 0.06 | |
Ir | Information ratio | 0.01 |
OKYO Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of OKYO Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for OKYO Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| OKYO Pharma has some characteristics of a very speculative penny stock | |
| OKYO Pharma had very high historical volatility over the last 90 days | |
| Net Loss for the year was (16.83 M) with loss before overhead, payroll, taxes, and interest of (3.6 M). | |
| OKYO Pharma Ltd currently holds about 2.06 M in cash with (9.49 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.1. | |
| OKYO Pharma has a frail financial position based on the latest SEC disclosures | |
| Roughly 28.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from gurufocus.com: OKYO Pharma to Participate at the 4th Annual BTIG Ophthalmology Conference |
OKYO Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of OKYO Stock often depends not only on the future outlook of the current and potential OKYO Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. OKYO Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 29.3 M | |
| Cash And Short Term Investments | 826.8 K |
OKYO Pharma Technical Analysis
OKYO Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. OKYO Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of OKYO Pharma Ltd. In general, you should focus on analyzing OKYO Stock price patterns and their correlations with different microeconomic environments and drivers.
OKYO Pharma Predictive Forecast Models
OKYO Pharma's time-series forecasting models is one of many OKYO Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary OKYO Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about OKYO Pharma
Checking the ongoing alerts about OKYO Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for OKYO Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| OKYO Pharma has some characteristics of a very speculative penny stock | |
| OKYO Pharma had very high historical volatility over the last 90 days | |
| Net Loss for the year was (16.83 M) with loss before overhead, payroll, taxes, and interest of (3.6 M). | |
| OKYO Pharma Ltd currently holds about 2.06 M in cash with (9.49 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.1. | |
| OKYO Pharma has a frail financial position based on the latest SEC disclosures | |
| Roughly 28.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from gurufocus.com: OKYO Pharma to Participate at the 4th Annual BTIG Ophthalmology Conference |
Check out OKYO Pharma Backtesting, OKYO Pharma Valuation, OKYO Pharma Correlation, OKYO Pharma Hype Analysis, OKYO Pharma Volatility, OKYO Pharma History as well as OKYO Pharma Performance. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OKYO Pharma. If investors know OKYO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OKYO Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.57) | Return On Assets (2.92) | Return On Equity (29.69) |
The market value of OKYO Pharma is measured differently than its book value, which is the value of OKYO that is recorded on the company's balance sheet. Investors also form their own opinion of OKYO Pharma's value that differs from its market value or its book value, called intrinsic value, which is OKYO Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OKYO Pharma's market value can be influenced by many factors that don't directly affect OKYO Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OKYO Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if OKYO Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OKYO Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.